These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 401823

  • 1. Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly.
    Nakagawa K, Obara T.
    J Clin Endocrinol Metab; 1977 Jan; 44(1):189-93. PubMed ID: 401823
    [Abstract] [Full Text] [Related]

  • 2. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
    Utsumi A, Hanew K, Sugawara A, Shimizu Y, Murakami O, Ikeda H, Yoshinaga K.
    J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H, Tamura T, Sasaki S, Takebe K.
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF, van Liessum PA, Smals AG, van Gennep JA, Benraad TJ, Kloppenborg PW.
    Acta Endocrinol Suppl (Copenh); 1987 Dec; 286():9-18. PubMed ID: 2892339
    [Abstract] [Full Text] [Related]

  • 7. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
    Ishibashi M, Yamaji T, Kosaka K.
    J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
    [Abstract] [Full Text] [Related]

  • 8. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G, Petroncini MM, Dallabonzana D, Cozzi R, Verde G, Chiodini PG, Liuzzi A.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of GH paradoxical responses to TRH and LHRH in acromegalic patients during long-term treatment with octreotide.
    Merola B, Colao A, Cataldi M, Rossi E, Selleri A, Briganti F, Schettini G, Bellastella A, Lombardi G.
    Horm Res; 1992 Dec; 37(1-2):18-22. PubMed ID: 1398471
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones.
    Salerno F, Cocchi D, Lampertico M, Manneschi M, Monza G, Müller EE.
    Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients.
    Yang I, Park S, Woo J, Kim S, Kim J, Kim Y, Choi Y.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2492-6. PubMed ID: 9253323
    [Abstract] [Full Text] [Related]

  • 15. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
    Cozzi R, Dallabonzana D, Oppizzi G, Verde G, Liuzzi A, Chiodini PG.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
    [Abstract] [Full Text] [Related]

  • 16. The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.
    Westwood ME, Butler GE, McLellan AC, Barth JH.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):727-33. PubMed ID: 10848877
    [Abstract] [Full Text] [Related]

  • 17. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N, Inoue K, Ishibashi M, Murayama Y, Koide Y, Ito K, Yamaji T, Yamashita K.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [Abstract] [Full Text] [Related]

  • 18. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J, Límanová Z, Srámková J.
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [Abstract] [Full Text] [Related]

  • 19. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Conte G, Sammartano L, Fabrizi ML, Valle D.
    Exp Clin Endocrinol Diabetes; 1996 Oct; 104(1):67-71. PubMed ID: 8750573
    [Abstract] [Full Text] [Related]

  • 20. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
    Natori S, Iguchi H, Nawata H, Kato K, Ibayashi H, Nakagaki H, Chrétien M.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.